Literature DB >> 25029349

Rhinovirus infection induces interleukin-13 production from CD11b-positive, M2-polarized exudative macrophages.

Yutein Chung1, Jun Young Hong, Jing Lei, Qiang Chen, J Kelley Bentley, Marc B Hershenson.   

Abstract

Rhinovirus (RV) causes asthma exacerbations. Previously, we showed that adherent bronchoalveolar cells from allergen-treated mice produce IL-13 when stimulated with RV ex vivo, implicating cells of the monocyte/macrophage lineage in viral-induced airway inflammation. In this study, we hypothesized that RV infection of allergen-treated mice results in IL-13 production by CD11b+ exudative macrophages in vivo. We sensitized and challenged BALB/c mice with ovalbumin (OVA), after which mice were inoculated with RV or sham HeLa cell lysate. After 1 day, lungs were harvested, and cell suspensions were analyzed by flow cytometry. We repeated this process in IL-13 reporter mice, CD11b-DTR mice in which diphtheria toxin selectively depletes CD11b+ cells, and chemokine receptor 2 (CCR2) null mice. We found that lungs of mice infected with RV alone showed increases in CD45+, CD68+, F4/80+, Ly6C+, and CD11b(high) cells, indicating an influx of inflammatory monocytes and exudative macrophages. The combination of OVA and RV had synergistic effects on the exudative macrophage number. However, CD11b+ cells from OVA-treated, RV-infected mice showed M2 polarization, including expression of CD206 and CD301 and production of IL-13. Similar results were obtained in IL-13 reporter mice. Diphtheria toxin depleted CD11b+, IL-13-producing cells in OVA-treated, RV-infected, CD11b-DTR mice, decreasing airway inflammation and responsiveness. CD11b+, Ly6C+ cells were reduced in CCR2 knockout mice. We conclude that, in contrast to naive mice, RV infection of mice with allergic airways disease induces an influx of IL-13-producing CD11b+ exudative macrophages bearing M2 macrophage markers. This finding further implicates alternatively activated macrophages in RV-induced asthma exacerbations.

Entities:  

Keywords:  alternative activation; asthma; exacerbation; innate immunity

Mesh:

Substances:

Year:  2015        PMID: 25029349      PMCID: PMC4370246          DOI: 10.1165/rcmb.2014-0068OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  43 in total

1.  Systemically dispersed innate IL-13-expressing cells in type 2 immunity.

Authors:  April E Price; Hong-Erh Liang; Brandon M Sullivan; R Lee Reinhardt; Chris J Eisley; David J Erle; Richard M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  More alternative activation of macrophages in lungs of asthmatic patients.

Authors:  Barbro N Melgert; Nick H ten Hacken; Bea Rutgers; Wim Timens; Dirkje S Postma; Machteld N Hylkema
Journal:  J Allergy Clin Immunol       Date:  2010-12-17       Impact factor: 10.793

3.  Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages.

Authors:  Deepti R Nagarkar; Emily R Bowman; Dina Schneider; Qiong Wang; Jee Shim; Ying Zhao; Marisa J Linn; Christina L McHenry; Babina Gosangi; J Kelley Bentley; Wan C Tsai; Umadevi S Sajjan; Nicholas W Lukacs; Marc B Hershenson
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

4.  IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway.

Authors:  Kelly M Kroeger; Brandon M Sullivan; Richard M Locksley
Journal:  J Leukoc Biol       Date:  2009-05-18       Impact factor: 4.962

Review 5.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

6.  Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children.

Authors:  Lily S Subrata; Joelene Bizzintino; Emilie Mamessier; Anthony Bosco; Katherine L McKenna; Matthew E Wikström; Jack Goldblatt; Peter D Sly; Belinda J Hales; Wayne R Thomas; Ingrid A Laing; Peter N LeSouëf; Patrick G Holt
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

7.  Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution.

Authors:  Ann C Palmenberg; David Spiro; Ryan Kuzmickas; Shiliang Wang; Appolinaire Djikeng; Jennifer A Rathe; Claire M Fraser-Liggett; Stephen B Liggett
Journal:  Science       Date:  2009-02-12       Impact factor: 47.728

8.  Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease.

Authors:  Edy Y Kim; John T Battaile; Anand C Patel; Yingjian You; Eugene Agapov; Mitchell H Grayson; Loralyn A Benoit; Derek E Byers; Yael Alevy; Jennifer Tucker; Suzanne Swanson; Rose Tidwell; Jeffrey W Tyner; Jeffrey D Morton; Mario Castro; Deepika Polineni; G Alexander Patterson; Reto A Schwendener; John D Allard; Gary Peltz; Michael J Holtzman
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

9.  MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness.

Authors:  Qiong Wang; David J Miller; Emily R Bowman; Deepti R Nagarkar; Dina Schneider; Ying Zhao; Marisa J Linn; Adam M Goldsmith; J Kelley Bentley; Umadevi S Sajjan; Marc B Hershenson
Journal:  PLoS Pathog       Date:  2011-05-26       Impact factor: 6.823

10.  Activated mast cells produce interleukin 13.

Authors:  P R Burd; W C Thompson; E E Max; F C Mills
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  17 in total

1.  Attenuation of Influenza A Virus Disease Severity by Viral Coinfection in a Mouse Model.

Authors:  Andres J Gonzalez; Emmanuel C Ijezie; Onesmo B Balemba; Tanya A Miura
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

Review 2.  Lung Macrophage Diversity and Asthma.

Authors:  Carey N Lumeng
Journal:  Ann Am Thorac Soc       Date:  2016-03

3.  Group 2 Innate Lymphoid Cells Must Partner with the Myeloid-Macrophage Lineage for Long-Term Postviral Lung Disease.

Authors:  Kangyun Wu; Xinyu Wang; Shamus P Keeler; Benjamin J Gerovac; Eugene V Agapov; Derek E Byers; Susan Gilfillan; Marco Colonna; Yong Zhang; Michael J Holtzman
Journal:  J Immunol       Date:  2020-07-08       Impact factor: 5.422

Review 4.  Rhinovirus Attributes that Contribute to Asthma Development.

Authors:  Mingyuan Han; Charu Rajput; Marc B Hershenson
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-07       Impact factor: 3.479

5.  Toll-like receptor 2-expressing macrophages are required and sufficient for rhinovirus-induced airway inflammation.

Authors:  Mingyuan Han; Yutein Chung; Jun Young Hong; Charu Rajput; Jing Lei; Joanna L Hinde; Qiang Chen; Steven P Weng; J Kelley Bentley; Marc B Hershenson
Journal:  J Allergy Clin Immunol       Date:  2016-04-12       Impact factor: 10.793

6.  Human Airway Epithelial Cells Direct Significant Rhinovirus Replication in Monocytic Cells by Enhancing ICAM1 Expression.

Authors:  Xu Zhou; Lingxiang Zhu; Rosa Lizarraga; Yin Chen
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

7.  Rhinovirus-induced airway cytokines and respiratory morbidity in severely premature children.

Authors:  Geovanny F Perez; Krishna Pancham; Shehlanoor Huseni; Amisha Jain; Carlos E Rodriguez-Martinez; Diego Preciado; Mary C Rose; Gustavo Nino
Journal:  Pediatr Allergy Immunol       Date:  2015-03       Impact factor: 6.377

8.  IL-1β prevents ILC2 expansion, type 2 cytokine secretion, and mucus metaplasia in response to early-life rhinovirus infection in mice.

Authors:  Mingyuan Han; Tomoko Ishikawa; Jennifer R Bermick; Charu Rajput; Jing Lei; Adam M Goldsmith; Caitlin R Jarman; Julie Lee; J Kelley Bentley; Marc B Hershenson
Journal:  Allergy       Date:  2020-03-10       Impact factor: 13.146

Review 9.  Effects of Allergic Sensitization on Antiviral Immunity: Allergen, Virus, and Host Cell Mechanisms.

Authors:  Regina K Rowe; Michelle A Gill
Journal:  Curr Allergy Asthma Rep       Date:  2017-02       Impact factor: 4.919

10.  Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism.

Authors:  Kittipong Maneechotesuwan; Kanda Kasetsinsombat; Adisak Wongkajornsilp; Peter J Barnes
Journal:  Respir Res       Date:  2016-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.